PDS Biotechnology Corpora...

NASDAQ: PDSB · Real-Time Price · USD
1.20
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
1.21
0.83%
After-hours: Aug 15, 2025, 06:03 PM EDT

PDS Biotechnology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
59.79K 57.33K 49.08K 246.39K
Gross Profit
-59.79K -57.33K -49.08K -246.39K
Operating Income
-36.32M -43.05M -41.67M -21.44M
Interest Income
2.52M 2.9M 935.18K 4.35K
Pretax Income
-38.48M -44.35M -42.05M -21.43M
Net Income
-37.61M -42.94M -40.85M -16.92M
Selling & General & Admin
13.7M 15.28M 12.24M 10.19M
Research & Development
22.57M 27.76M 29.43M 11.26M
Other Expenses
-1K 1K n/a -1K
Operating Expenses
36.26M 43.05M 41.67M 21.44M
Interest Expense
4.67M 4.21M 1.32M n/a
Selling & Marketing Expenses
264K 264K n/a n/a
Cost & Expenses
-36.32M 43.05M 41.67M 21.44M
Income Tax Expense
-869K -1.41M -1.2M -4.52M
Shares Outstanding (Basic)
36.45M 30.95M 28.6M 25.6M
Shares Outstanding (Diluted)
36.45M 30.95M 28.6M 25.6M
EPS (Basic)
-1.03 -1.39 -1.43 -0.66
EPS (Diluted)
-1.03 -1.39 -1.43 -0.66
EBITDA
-33.75M -40.09M -40.69M -21.19M
EBIT
-33.81M -40.14M -40.74M -21.43M
Depreciation & Amortization
59.79K 57.33K 49.08K 246.39K